Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
Kamran Ghoreschi(National Institutes of Health), John J. O’Shea(National Institute of Arthritis and Musculoskeletal and Skin Diseases)
Cited by 634
Related Papers
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
|European Journal of Cancer|2021|246
Variant <i>STAT4</i> and Response to Ruxolitinib in an Autoinflammatory Syndrome
|New England Journal of Medicine|2023|78
STAM2, a new member of the STAM family, binding to the Janus kinases
|FEBS Letters|2000|76
Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation
|Scientific Reports|2017|35